BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31287704)

  • 1. Glass Transition Dynamics and Physical Stability of Amorphous Griseofulvin in Binary Mixtures with Low-
    Tu W; Knapik-Kowalczuk J; Chmiel K; Paluch M
    Mol Pharm; 2019 Aug; 16(8):3626-3635. PubMed ID: 31287704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitigating unwanted amorphisation: A screening method for the selection of suitable excipients.
    Amharar Y; Curtin V; Gallagher KH; O'Siochru E; O'Connell P; Healy AM
    Eur J Pharm Sci; 2016 Jan; 81():181-8. PubMed ID: 26493586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Dynamics and Physical Stability of Ibuprofen in Binary Mixtures with an Acetylated Derivative of Maltose.
    Grzybowska K; Grzybowski A; Knapik-Kowalczuk J; Chmiel K; Woyna-Orlewicz K; Szafraniec-Szczęsny J; Antosik-Rogóż A; Jachowicz R; Kowalska-Szojda K; Lodowski P; Paluch M
    Mol Pharm; 2020 Aug; 17(8):3087-3105. PubMed ID: 32584584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Factors Governing the Liquid and Glassy States Recrystallization of Celecoxib in Binary Mixtures with Excipients of Different Molecular Weights.
    Grzybowska K; Chmiel K; Knapik-Kowalczuk J; Grzybowski A; Jurkiewicz K; Paluch M
    Mol Pharm; 2017 Apr; 14(4):1154-1168. PubMed ID: 28241116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceleration of Crystal Growth of Amorphous Griseofulvin by Low-Concentration Poly(ethylene oxide): Aspects of Crystallization Kinetics and Molecular Mobility.
    Shi Q; Zhang C; Su Y; Zhang J; Zhou D; Cai T
    Mol Pharm; 2017 Jul; 14(7):2262-2272. PubMed ID: 28548840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of griseofulvin and hydroxypropylmethyl cellulose acetate succinate miscibility in ball milled solid dispersions.
    Al-Obaidi H; Lawrence MJ; Al-Saden N; Ke P
    Int J Pharm; 2013 Feb; 443(1-2):95-102. PubMed ID: 23299082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining crystalline and polymeric excipients in API solid dispersions - Opportunity or risk?
    Veith H; Wiechert F; Luebbert C; Sadowski G
    Eur J Pharm Biopharm; 2021 Jan; 158():323-335. PubMed ID: 33296719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the capacity of low glass transition temperature excipients to minimize amorphization of sulfadimidine on comilling.
    Curtin V; Amharar Y; Hu Y; Erxleben A; McArdle P; Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2013 Jan; 10(1):386-96. PubMed ID: 23186332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of the physical stability of amorphous indomethacin by mixing it with octaacetylmaltose. inter and intra molecular studies.
    Kaminska E; Adrjanowicz K; Zakowiecki D; Milanowski B; Tarnacka M; Hawelek L; Dulski M; Pilch J; Smolka W; Kaczmarczyk-Sedlak I; Kaminski K
    Pharm Res; 2014 Oct; 31(10):2887-903. PubMed ID: 24831310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of Thermal Properties, Molecular Dynamics, and Physical Stability of Etoricoxib Mixtures with Octaacetylmaltose near the Glass Transition.
    Grzybowska K; Rams-Baron M; Łucak K; Grzybowski A; Paluch M
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutual Impact of Phase Separation/Crystallization and Water Sorption in Amorphous Solid Dispersions.
    Luebbert C; Wessner M; Sadowski G
    Mol Pharm; 2018 Feb; 15(2):669-678. PubMed ID: 29309155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermodynamics, molecular mobility and crystallization kinetics of amorphous griseofulvin.
    Zhou D; Zhang GG; Law D; Grant DJ; Schmitt EA
    Mol Pharm; 2008; 5(6):927-36. PubMed ID: 19434849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of Low-concentration Polymer on the Physical Stability of Glassy Griseofulvin: Role of the Segmental Mobility.
    Wang Y; Chin CY; Shivashekaregowda NKH; Shi Q
    AAPS PharmSciTech; 2024 May; 25(5):103. PubMed ID: 38714634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hot melt extrusion (HME) for amorphous solid dispersions: predictive tools for processing and impact of drug-polymer interactions on supersaturation.
    Sarode AL; Sandhu H; Shah N; Malick W; Zia H
    Eur J Pharm Sci; 2013 Feb; 48(3):371-84. PubMed ID: 23267847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermodynamic and kinetic evaluation of the impact of polymer excipients on storage stability of amorphous itraconazole.
    Zhang S; Lee TWY; Chow AHL
    Int J Pharm; 2019 Jan; 555():394-403. PubMed ID: 30513399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-Excipient Interactions: Effect on Molecular Mobility and Physical Stability of Ketoconazole-Organic Acid Coamorphous Systems.
    Fung MH; DeVault M; Kuwata KT; Suryanarayanan R
    Mol Pharm; 2018 Mar; 15(3):1052-1061. PubMed ID: 29309158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Throughput Raman Spectroscopy Screening of Excipients for the Stabilization of Amorphous Drugs.
    Chen X; Stoneburner K; Ladika M; Kuo TC; Kalantar TH
    Appl Spectrosc; 2015 Nov; 69(11):1271-80. PubMed ID: 26647050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidation of Compression-Induced Surface Crystallization in Amorphous Tablets Using Sum Frequency Generation (SFG) Microscopy.
    Mah PT; Novakovic D; Saarinen J; Van Landeghem S; Peltonen L; Laaksonen T; Isomäki A; Strachan CJ
    Pharm Res; 2017 May; 34(5):957-970. PubMed ID: 27738954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of Glass Forming Ability on the Physical Stability of Supersaturated Amorphous Solid Dispersions.
    Blaabjerg LI; Bulduk B; Lindenberg E; Löbmann K; Rades T; Grohganz H
    J Pharm Sci; 2019 Aug; 108(8):2561-2569. PubMed ID: 30878513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Dynamics, Recrystallization Behavior, and Water Solubility of the Amorphous Anticancer Agent Bicalutamide and Its Polyvinylpyrrolidone Mixtures.
    Szczurek J; Rams-Baron M; Knapik-Kowalczuk J; Antosik A; Szafraniec J; Jamróz W; Dulski M; Jachowicz R; Paluch M
    Mol Pharm; 2017 Apr; 14(4):1071-1081. PubMed ID: 28231007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.